Integra LifeSciences Holdings Corporation (Nasdaq: IART [FREE Stock Trend Analysis]) today announced that it has received European CE Mark Certification for its Integra^® Flowable Wound Matrix, an advanced device approved in the European Union for filling deep soft tissue or tunneling wounds, including diabetic foot and leg ulcers.
